Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.69659 | 29 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.67859 | 30 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.67932 | 30 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.65296 | 31 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.6188 | 29 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.76376 | 30 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.6796 | 28 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.66098 | 30 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.63936 | 29 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.67337 | 30 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.66095 | 30 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.65774 | 30 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.75831 | 33 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.67226 | 30 |